Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.433NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.482NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
HK.3.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HK.3.5NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
GY.1.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GY.1.1.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
HK.3.11NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HK.3.11NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
JC.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JC.4NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.564NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.564NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.46 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AY.46 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.99 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AY.99 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.120.2 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AY.120.2 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.528NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.528NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
C.1.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
C.1.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.91 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AY.91 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.189NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.189NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.1.13NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.1.13NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
C.13NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
C.13NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
C.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
C.4NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.545NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.545NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.482NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
W.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
W.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.565NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.565NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.361NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.361NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.101NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.101NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.478NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.478NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.177.86NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.177.86NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.216NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.216NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.471NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used